Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab (Humira) in the treatment of chronic pouchitis
2011-004268-31Phase 3Completed
- Sponsor
- University Hospital Odense
- Start
- Nov 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of adalimumab in pouchitis and autoimmune colitis, sponsored by University Hospital Odense. Primary endpoint: Clinical improvement within 12 weeks. Started Nov 2011; status: completed.
02
Drugs
03
Conditions
pouchitisautoimmune colitis
Beyond the preview
Go deeper on 2011-004268-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004268-31.